Early diagnostic and prognostic utility of high-sensitive troponin assays in acute myocardial infarction: A meta-analysis

Internal Medicine Journal

Volumn 45, Issue 7, 2015, Pages 748-756

  Li, W J ^a,b   Chen, X M ^a   Nie, X Y ^a   Lin, X X ^a   Cheng, Y J ^a   Hu, C H ^a   Du, Z M ^a   Dong, Y G ^a   Ma, H ^a   Wu, S H ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Diagnostic utility; High sensitive troponin assay; Meta analysis; Prognostic utility

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; LIMIT OF DETECTION; ONSET AGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; BLOOD; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDY;

BIOMARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 84933519985     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12642     Document Type: Article

References (33)

1. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M etal. Universal definition of myocardial infarction. Circulation 2012; 116: 2634-2653.
2. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr etal. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2011; 123: e426-579.
3. Hoenig MR, Doust JA, Aroney CN, Scott IA. Early invasive versus conservative strategies for unstable angina & non ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev 2006; (3): CD004815.
4. Wang K, Asinger RW, Marriott HJ. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003; 349: 2128-2135.
5. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
6. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006; 48: 1-11.
7. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and clinical trials. Am Heart J 2002; 144: 981-986.
8. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, National Academy of Clinical Biochemistry etal. National academy of clinical biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007; 115: e352-355.
9. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
10. Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989; 81: 107-115.
11. Devillé WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA etal. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002; 2: 9.
12. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
13. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384.
14. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
15. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S etal. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858-867.
16. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E etal. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361: 868-877.
17. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K etal. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. JACC 2011; 58: 1332-1339.
18. Freund Y, Gobeaux CC, Bonnet P, Claessens YE, Allo JC, Doumenc B etal. High-sensitivity versus conventional troponin in the emergency department for the diagnosis of acute myocardial infarction. Critical Care 2011; 15: R147.
19. Melki D, Lind S, Agewall S, Jernbrg T. Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation. Clin Chim Acta 2012; 413: 933-937.
20. Aldous SJ, Richards M, Cullen L, Troughton R, Than M. Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain. CMAJ 2012; 184: e260-268.
21. Hochholzer W, Reichlin T, Twerenbold R, Stelzig C, Hochholzer K, Meissner J etal. Incremental value of high-sensitivity cardiac troponin t for risk prediction in patients with suspected acute myocardial infarction. Clin Chem 2011; 57: 1318-1326.
22. Daubert MA, Jeremias A. The utility of troponin measurement to detect myocardial infarction: review of the current findings. Vasc Health Risk Manag 2010; 6: 691-698.
23. Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008; 46: 1489-1500.
24. Adams JE 3rd, Bodor GS, Dávila-Román VG, Delmez JA, Apple FS, Ladenson JH etal. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993; 88: 101-106.
25. Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R etal. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012; 58: 219-225.
26. Patil H, Vaidya O, Bogart D. A review of causes and systemic approach to cardiac troponin elevation. Clin Cardiol 2011; 34: 723-728.
27. Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag 2011; 7: 597-603.
28. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W etal. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011; 124: 136-145.
29. Aldous SJ, Richards M, Cullen L, Than MP. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin Chem 2011; 57: 1154-1160.
30. Meune C, Twerenbold R, Drexler B, Balmelli C, Wolf C, Haaf P etal. Midregional Pro-A-Type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction. Am J Cardiol 2012; 109: 1117-1123.
31. Santaló M, Martin A, Velilla J, Povar J, Temboury F, Balaguer J etal. Using high-sensitivity troponin T: the importance of the proper gold standard. Am J Med 2013; 126: 709-717.
32. Nawar EW, Niska RW, Xu J. National hospital ambulatory medical care survey: 2005 emergency department summary: advance data from vital and health statistics. Cent Dis Control Prev 2007; 386: 1-32.
33. Twerenbold R, Reichlina T, Reiter M, Mueller C. High-sensitive cardiac troponin: friend or foe? Swiss Med Wkly 2011; 141: w13202.